Orphan drugs: Latest News, Top Stories & Analysis - Page 2 of 2

HORSHAM, PA — In a significant medical breakthrough, Johnson & Johnson recently announced FDA’s approval of CARVYKTI® for the treatment of adult patients with multiple myeloma. This approval marks a …

Regional

ArriVent BioPharma Unveils Promising Developments and Strong Financial Performance in 2023

April 1, 2024March 31, 2024 - by Timothy Alexander

NEWTOWN SQUARE, PA — In recent developments from the pharmaceutical industry, ArriVent BioPharma Inc. (Nasdaq: AVBP), a notable player in the arena of breakthrough cancer therapy, has seen a transformative …